Menopause is a biological transition, not a disease. But for the skeleton it can be a turning point.
As estrogen levels fall, bone remodelling changes and bone loss can accelerate. The remarkable part is how differently women can respond — even when they share much of the same genetic background.
Quick answer
Why does osteoporosis become more common after menopause?
Loss of estrogen shifts bone remodelling toward greater bone resorption, contributing to faster bone loss. Genetics influences both bone density and aspects of bone-loss rate, but individual risk also depends on age, prior bone mass, health, medication, activity, nutrition and other factors.
Key takeaways
- Estrogen loss is a central biological driver of postmenopausal bone loss.
- A longitudinal study of 724 female twins estimated genetic effects at about 40% of variation in bone loss at several skeletal sites.
- The genetic pattern was not identical at every bone site.
- Menopause does not make osteoporosis inevitable, and two women with similar genetics can follow different trajectories.
- Personal fracture-risk assessment cannot be replaced by family history or a twin-study percentage.
Bone is living tissue, not a static frame
Bone is continuously remodelled. Cells remove older bone and other cells build new bone. Estrogen helps regulate that balance.
Around and after menopause, the fall in estrogen can increase bone resorption relative to formation. Over time, that can reduce bone mass and weaken skeletal microarchitecture.
What 724 female twins revealed
Researchers studied 724 female twins aged 45–82, measuring BMD at baseline and again over an average of 4.9 years.
Genetic modelling suggested that about 40% of between-person variation in bone loss at the lumbar spine, forearm and whole body was attributable to genetic effects. The same clear genetic contribution was not demonstrated at every hip site.
Same transition, different trajectory
Two women can pass through menopause at similar ages yet lose bone at different rates. Twin studies help show why a universal prediction is unrealistic.
Starting BMD, body composition, physical loading, smoking, alcohol, illness, medication, calcium and vitamin D status, falls and many other factors can differ. Some are modifiable; others are not. Their importance also changes with age.
Strength training, nutrition and the limits of a research article
Weight-bearing and resistance exercise are widely relevant to musculoskeletal health, and adequate nutrition is part of normal bone maintenance. But an educational article cannot prescribe an osteoporosis treatment plan.
For a person with fragility fractures, major risk factors, symptoms or concern about bone loss, clinical assessment may include an individualized history, fracture-risk evaluation and, when appropriate, bone-density testing.
TwinPare perspective: ageing is not one-size-fits-all biology
Female twin research makes a larger point visible: menopause is shared physiology, but its consequences are individualized.
That is why TwinPare Research focuses on variation rather than miracle rules. The scientifically useful question is not “what happens to every woman?”, but “which factors help explain why women with similar starting points diverge?”
Source notes
The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [makovey-2007] Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study J Makovey et al.. Journal of Bone and Mineral Research, 2007. Evidence type: Longitudinal study of 724 female twins with repeat DXA over an average 4.9 years Limitation: Genetic effects accounted for about 40% of between-person variation in bone loss at several sites, but not all sites. The estimate describes variation in the studied population, not personal destiny. PubMed DOI
- [singer-2026] Bone Health and Osteoporosis Prevention in Menopause Andrea J Singer. Obstetrics and Gynecology Clinics of North America, 2026. Evidence type: Current clinical review of menopause-related bone loss, fracture-risk assessment and osteoporosis prevention Limitation: The review describes accelerated bone loss during the menopausal transition and emphasizes individualized fracture-risk assessment. It supports general context, not personal diagnosis or treatment through this article. PubMed DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Do not describe menopause alone as a diagnosis of osteoporosis.
- Do not imply that lifestyle can eliminate genetically or hormonally influenced risk.
- Treatment, testing and supplementation require individualized clinical context.
| ID | Claim | Source support | Caution |
|---|